C12Y 203/01051
1-acylglycerol-3-phosphate o-acyltransferase
Official title: 1-Acylglycerol-3-phosphate O-acyltransferase (2.3.1.51)
C12Y203/01051 (1-acylglycerol-3-phosphate o-acyltransferase) appears on 24 US grants and 45 published applications in this corpus.
Search patents in C12Y- Granted patents
- 24
- Published applications
- 45
- Assignees
- 26
- Inventors
- 90
- Latest grant
- 22 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 7 |
| 2014 | 1 | 1 |
| 2015 | 6 | 0 |
| 2016 | 1 | 6 |
| 2017 | 2 | 3 |
| 2018 | 3 | 3 |
| 2019 | 3 | 1 |
| 2020 | 4 | 3 |
| 2021 | 0 | 3 |
| 2022 | 2 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 6 |
| 2025 | 1 | 7 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Saccharomyces cerevisiae strain for producing human milk lipid substitute and use thereof22 Jul 2025US 12,365,926 B2Inner Mongolia Mengniu Dairy (Group) Co., Ltd.
- Modulators of PNPLA3 expression10 Oct 2023US 11,781,143 B2Ionis Pharmaceuticals, Inc.
- Structuring fats and methods of producing structuring fats2 Aug 2022US 11,401,538 B2Corbion Biotech, Inc.
- ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases26 Apr 2022US 11,312,943 B2Ruprecht-Karls-UniversitäT Heidelberg
- Acyltransferases and methods of using15 Dec 2020US 10,865,421 B2NUtech Ventures
- Compositions and methods for inhibiting expression of patatin-like phospholipase domain-containing 3 (pnpla3)16 Jul 2026US 2026/0201387 A1Shanghai Argo Biopharmaceutical Co., Ltd.
- Rnai constructs for inhibiting pnpla3 expression and methods of use thereof16 Oct 2025US 2025/0320502 A1Amgen Inc.
- Methods and compositions for producing plants having high vegetative fatty acids25 Sep 2025US 2025/0297272 A1NUtech Ventures
- Regiospecific incorporation of fatty acids in triglyceride oil18 Sep 2025US 2025/0290105 A1Checkerspot, Inc.
- Rnai constructs for inhibiting pnpla3 expression and methods of use thereof26 Jun 2025US 2025/0207138 A1Amgen Inc.
Most cited
By later US patents
- Tailored oils36US 8,945,908 B2Solazyme, Inc. · 2015
- Tailored oils35US 8,846,375 B2Solazyme, Inc. · 2014
- Microorganisms expressing ketoacyl-CoA synthase and uses thereof34US 9,068,213 B2Solazyme, Inc. · 2015
- Tailored oils29US 9,102,973 B2Solazyme, Inc. · 2015
- Tailored oils24US 9,200,307 B2Solazyme, Inc. · 2015